Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

NMDA antagonists improve memory deficits after brain injury in the rat

June 26, 1997

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

June 26, 1997

Efficacy of SB-206284A in animal models of cerebral ischemia

June 26, 1997

MS&D prepares potent and selective 5-HT1D agonists

June 26, 1997

Selective dopamine D3 receptor ligands from Novo Nordisk

June 26, 1997

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

June 26, 1997

Novel melatonergic agents described by Bristol-Myers Squibb

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...